• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

易于制备单羧酸盐、二羧酸盐和混合羧酸盐的铂(IV)配合物,用于多功能抗癌前药设计。

Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design.

机构信息

School of Chemistry, The University of Sydney, Sydney, N.S.W., Australia.

出版信息

Chemistry. 2013 Jan 28;19(5):1672-6. doi: 10.1002/chem.201203159. Epub 2012 Dec 18.

DOI:10.1002/chem.201203159
PMID:23255183
Abstract

Facile strategies were developed for the versatile functionalization of platinum(IV) axial sites, allowing for easy accessibility to unsymmetric mono- and mixed-carboxylato, as well as symmetric di-substituted platinum(IV) complexes. The first method involves the direct oxidation and carboxylation of the platinum(II) center using an appropriate peroxide and the carboxylate of choice to firstly yield a monocarboxylato monohydroxido platinum(IV) complex. This platinum(IV) intermediate can undergo further carboxylation to give rise to a mixed-carboxylato platinum(IV) complex. The second method involves the activation of the carboxylate of choice by a common carbodiimide coupling reagent, and its reaction with a dihydroxido platinum(IV) precursor to give the monocarboxylato platinum(IV) complex. Uronium salts can be employed to promote efficient dicarboxylation of the dihydroxido platinum(IV) precursor. Lastly, an axial azide pendant group was demonstrated to be suitable for orthogonal "click" conjugation reactions.

摘要

开发了简便的策略来实现铂(IV)轴向位置的多功能官能化,使不对称的单羧基和混合羧基以及对称的二取代铂(IV)配合物易于获得。第一种方法涉及使用适当的过氧化物和所需的羧酸盐直接氧化和羧化铂(II)中心,首先生成单羧基单羟基金属(IV)配合物。该铂(IV)中间体可以进一步进行羧化反应,生成混合羧基铂(IV)配合物。第二种方法涉及通过常见的碳二亚胺偶联试剂活化所需的羧酸盐,然后使其与二羟基金属(IV)前体反应,得到单羧基铂(IV)配合物。可以使用尿嘧啶盐来促进二羟基金属(IV)前体的高效二羧化反应。最后,展示了轴向叠氮基团适合正交“点击”共轭反应。

相似文献

1
Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design.易于制备单羧酸盐、二羧酸盐和混合羧酸盐的铂(IV)配合物,用于多功能抗癌前药设计。
Chemistry. 2013 Jan 28;19(5):1672-6. doi: 10.1002/chem.201203159. Epub 2012 Dec 18.
2
Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.3,6-二氧杂-1,8-辛二硫醇被铂(IV)抗癌前药和模型配合物氧化:动力学和机理研究。
J Phys Chem B. 2012 Jun 7;116(22):6522-8. doi: 10.1021/jp302600a. Epub 2012 May 22.
3
Dependence of the reduction products of platinum(IV) prodrugs upon the configuration of the substrate, bulk of the carrier ligands, and nature of the reducing agent.铂(IV)前药还原产物对载体配体的结构、体积和还原剂性质的依赖性。
Inorg Chem. 2012 Sep 17;51(18):9694-704. doi: 10.1021/ic300957v. Epub 2012 Aug 24.
4
Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells.赤道和轴向羧基配体对天冬氨酸和半胱氨酸存在下及在 DLD-1 癌细胞内顺铂(IV)配合物动力学惰性的影响。
J Med Chem. 2013 Nov 14;56(21):8757-64. doi: 10.1021/jm401218n. Epub 2013 Oct 31.
5
Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.通过氧化溴化反应制备的单溴和二溴铂(IV)前药:合成、表征及细胞毒性
Dalton Trans. 2015 Dec 14;44(46):19918-26. doi: 10.1039/c5dt03101j.
6
Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.基于奥沙利铂的含一个轴向氟的铂(IV)抗癌前药的合成、结构和细胞毒性。
Inorg Chem. 2018 Jul 16;57(14):8227-8235. doi: 10.1021/acs.inorgchem.8b00706. Epub 2018 Jun 26.
7
Design and investigation of photoactivatable platinum(iv) prodrug complexes of cisplatin.顺铂光活化前药配合物的设计与研究。
Dalton Trans. 2019 Jun 7;48(21):7388-7393. doi: 10.1039/c9dt00540d. Epub 2019 Apr 8.
8
Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs.优化轴向配体以促进 BODIPY 缀合的顺铂(IV)抗癌前药的光活化。
Dalton Trans. 2021 Oct 12;50(39):13737-13747. doi: 10.1039/d1dt02362d.
9
What do we know about the reduction of Pt(IV) pro-drugs?我们对 Pt(IV)前药的还原了解多少?
J Inorg Biochem. 2012 Dec;117:220-9. doi: 10.1016/j.jinorgbio.2012.06.013. Epub 2012 Jul 2.
10
Reactions of a photoactivatable diazido Pt(iv) anticancer complex with a single-stranded oligodeoxynucleotide.光活化的叠氮基 Pt(iv) 抗癌配合物与单链寡脱氧核苷酸的反应。
Dalton Trans. 2020 Aug 18;49(32):11249-11259. doi: 10.1039/d0dt02208j.

引用本文的文献

1
Pt(IV) Complexes as Anticancer Drugs and Their Relationship with Oxidative Stress.铂(IV)配合物作为抗癌药物及其与氧化应激的关系。
Biomedicines. 2025 Apr 17;13(4):981. doi: 10.3390/biomedicines13040981.
2
Enhancing anti-tumor immunity through intratumoral combination therapy with amphiphilic conjugates of oxaliplatin and imidazoquinoline TLR7/8 agonist.通过奥沙利铂与咪唑喹啉TLR7/8激动剂的两亲性缀合物进行瘤内联合治疗增强抗肿瘤免疫力。
RSC Adv. 2025 Apr 14;15(15):11662-11674. doi: 10.1039/d5ra00163c. eCollection 2025 Apr 9.
3
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth-An Investigation of the Activation Mechanism and Their Nanoformulation.
吉西他滨和卡培他滨功能化的奥沙利铂(IV)前药诱导结直肠癌细胞生长阻滞——激活机制及其纳米制剂的研究
Pharmaceutics. 2024 Feb 16;16(2):278. doi: 10.3390/pharmaceutics16020278.
4
Pyrenebutyrate Pt(IV) Complexes with Nanomolar Anticancer Activity.具有纳摩尔抗癌活性的丁酸芘铂(IV)配合物
Pharmaceutics. 2023 Sep 13;15(9):2310. doi: 10.3390/pharmaceutics15092310.
5
Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models.具有显著抗癌活性的铂(IV)-金(I)制剂:二维和三维三阴性乳腺癌模型中的精选研究
Chemistry. 2023 Oct 23;29(59):e202302045. doi: 10.1002/chem.202302045. Epub 2023 Sep 5.
6
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs.肿瘤靶向双作用非甾体抗炎药-铂(IV)抗癌前药
Inorg Chem Front. 2023 Jun 28;10(14):4126-4138. doi: 10.1039/d3qi00968h. eCollection 2023 Jul 11.
7
Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes-A More Selective Anticancer Treatment?聚酰胺-胺型树枝状大分子的药物递送特性与铂(IV)配合物的细胞毒性的结合——一种更具选择性的抗癌治疗方法?
Pharmaceutics. 2023 May 17;15(5):1515. doi: 10.3390/pharmaceutics15051515.
8
Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform.负载铂(IV)的降解壳聚糖二醇作为高效的铂(IV)药物递送平台。
Pharmaceutics. 2023 Mar 24;15(4):1050. doi: 10.3390/pharmaceutics15041050.
9
A New Manganese Superoxide Dismutase Mimetic Improves Oxaliplatin-Induced Neuropathy and Global Tolerance in Mice.一种新型锰过氧化物歧化酶模拟物可改善奥沙利铂诱导的小鼠神经病变和整体耐受性。
Int J Mol Sci. 2022 Oct 26;23(21):12938. doi: 10.3390/ijms232112938.
10
Heavy-Metal Trojan Horse: Enterobactin-Directed Delivery of Platinum(IV) Prodrugs to .重金属木马:enterobactin 导向的铂(IV)前药递送至.
J Am Chem Soc. 2022 Jul 20;144(28):12756-12768. doi: 10.1021/jacs.2c03324. Epub 2022 Jul 8.